MAZE Q1 2026 Earnings EPS Surprises to the Upside Revenue Yet to Materialize Supernus Pharmaceuticals SUPN Q1 2026 Earnings EPS Surges Past Expectations but Stock Retreats STLA Q1 2026 Earnings EPS Misses Estimates as Company Navigates Transition Challenges XOMAP Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Royalty Fluctuations Sunshine Biopharma Inc SBFM Q1 2026 Earnings Reported Loss Per Share of 025 Stock Declines 68 Textron Q1 2026 Earnings Strong EPS Surprise Drives Modest Stock Gain